MediWound (MDWD) Cash from Financing Activities (2013 - 2025)

MediWound's Cash from Financing Activities history runs 13 years deep, the most recent figure standing at -$1.1 million for Q4 2025.

• On a quarterly basis, Cash from Financing Activities fell 112.87% year-over-year to -$1.1 million in Q4 2025; TTM through Dec 2025 was $29.6 million, a 52.73% increase from a year earlier, with the FY2025 full-year figure at $29.6 million, up 52.73% from the prior year.
• Cash from Financing Activities retreated to -$1.1 million in Q4 2025 per MDWD's latest filing, from $30.5 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $30.5 million in Q3 2025 and bottomed at -$1.1 million in Q4 2025.
• The 5-year median for Cash from Financing Activities is -$177000.0 (2021), against an average of $5.4 million.
• Biggest YoY gain for Cash from Financing Activities was 4554.42% in 2021; the steepest drop was 808.0% in 2021.
• Year by year, Cash from Financing Activities stood at -$177000.0 in 2021, then plunged by 311.3% to -$728000.0 in 2022, then soared by 71.98% to -$204000.0 in 2023, then sank by 151.47% to -$513000.0 in 2024, then slumped by 112.87% to -$1.1 million in 2025.
• Per Business Quant, the three latest MDWD Cash from Financing Activities figures stand at -$1.1 million (Q4 2025), $30.5 million (Q3 2025), and $549000.0 (Q2 2025).